By 2021, nearly 2,000 volunteers had answered the call to test an experimental Alzheimer’s drug known as BAN2401. For the drugmaker Eisai, the trial was a shot at a windfall — potentially billions of dollars — for defanging a disease that had confounded researchers for more than a century. To …
Read More »Sammy Basso, Advocate for Progeria Research, Is Dead at 28
Sammy Basso, an advocate for research into progeria, an ultrarare fatal disease that causes rapid aging in children, who was known for living with gusto and humor with the condition as he faced the certainty of premature death, died on Oct. 5 near his home in Tezze sul Brenta, in …
Read More »Opinion | Why We May Soon Use Ozempic to Treat Addiction
In late 2016, Steven Klein realized that he’d lost control over his drinking and stimulant use. He became sober that December, with help from 12-step meetings. But he also struggled with overeating, which he views as another addiction. Stress from the pandemic caused him to gain more than 40 pounds …
Read More »